Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Nov 8, 2022
Trial Information
Current as of August 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • We are recruiting 50 parent-child dyads. Childs are the participant undergoing the exercise intervention. Parents are required to support the safety and schedule of the child participant. Parents are considered participants due to their responsibilities.
- Inclusion Criteria:
- • have a medical diagnosis of cerebral palsy, as determined by ICD-10 codes
- • aged 6-17 years old
- • a Gross Motor Function Classification System Level I-III (as determined via participant screening, explained in the protocol section below)
- • medical clearance to participate in high-intensity exercise from a physician (using the attached medical screening form and explained in the intervention safety, monitoring, and response plan)
- • access to a Wi-Fi Internet connection in the home via mobile phone or tablet computer
- • a caregiver who will support and monitor the participant's safety during the intervention and manage the child's exercise schedule.
- Exclusion Criteria:
- • physically active (defined as \>150 minutes per week of self-reported moderate-to-vigorous intensity exercise in a typical week)
- • cannot use their arms for exercise
- • a Gross Motor Function Classification Level of IV-V
- • complete blindness or deafness;
- • Any past history of a contraindication to exercise testing according to American College of Sports Medicine (ACSM) guidelines (Liguori and American College of Sports Medicine, 2020): significant change in the resting electrocardiogram suggesting significant ischemia, myocardial infarction, or other cardiac event, unstable angina, uncontrolled cardiac dysrhythmias causing symptoms or hemodynamic compromise, symptomatic severe aortic stenosis, uncontrolled symptomatic heart failure, pulmonary embolus or pulmonary infarction, myocarditis or pericarditis, aneurysm.
- • pregnant (due to radiation from a Dual Energy X-ray Absorptiometry \[DEXA\] scan)
- • has not been seen by a physician within the last year
- • uses a g-tube
- • Eligible caregivers will include parents or legal guardians of the child, who can commit sufficient time to support the child in their roles for the study and communicate in English. Caregivers who have complete blindness or deafness will be excluded from participation.
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Homewood, Alabama, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials